Carbonic anhydrase inhibitors. Inhibition of the fungal β-carbonic anhydrases from Candida albicans and Cryptococcus neoformans with boronic acids

被引:47
作者
Innocenti, Alessio [1 ]
Winum, Jean-Yves [2 ]
Hall, Rebecca A. [3 ]
Muehlschlegel, Fritz A. [3 ]
Scozzafava, Andrea [2 ]
Supuran, Claudiu T. [1 ]
机构
[1] Univ Florence, Lab Chim Bioinorgan, I-50019 Florence, Italy
[2] Ecole Natl Super Chim Montpellier, IBMM, CNRS UM1 UM2, UMR 5247, F-34296 Montpellier, France
[3] Univ Kent, Dept Biosci, Canterbury CT2 7NJ, Kent, England
基金
英国生物技术与生命科学研究理事会;
关键词
Carbonic anhydrase; Beta-class enzyme; Cryptococcus neoformans; Candida albicans; Can2; Nce103; Boronic acid; ISOZYME-IV; CLASS ENZYMES; ANIONS; PROTEASOME; VIRULENCE; POTENT; CO2; IX; CARBOXYLATES; BORTEZOMIB;
D O I
10.1016/j.bmcl.2009.03.147
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Inhibition of the beta-carbonic anhydrases (CAs, EC 4.2.1.1) from the pathogenic fungi Cryptococcus neoformans (Can2) and Candida albicans (Nce103) with a series of aromatic, arylalkenyl- and arylalkylboronic acids was investigated. Aromatic, 4-phenylsubstituted- and 2-naphthylboronic acids were the best Can2 inhibitors, with inhibition constants in the range of 8.5-11.5 mu M, whereas arylalkenyl and aryalkylboronic acids showed K(I)s in the range of 428-3040 mu M. Nce103 showed a similar inhibition pro. le, with the 4-phenylsubstituted- and 2-naphthylboronic acids possessing K(I)s in the range of 7.8-42.3 mu M, whereas the arylalkenyl and aryalkylboronic acids were weaker inhibitors (K(I)s of 412-5210 mu M). The host human enzymes CAI and II were also effectively inhibited by these boronic acids. The B(OH)(2) moiety is thus a new zinc-binding group for designing effective inhibitors of the alpha- and beta-CAs. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2642 / 2645
页数:4
相关论文
共 36 条
[1]   Development of the proteasome inhihitor Veleade™ (Bortezomib) [J].
Adams, J ;
Kauffman, M .
CANCER INVESTIGATION, 2004, 22 (02) :304-311
[2]   The proteasome: A suitable antineoplastic target [J].
Adams, J .
NATURE REVIEWS CANCER, 2004, 4 (05) :349-360
[3]   Carbonic anhydrase and CO2 sensing during Cryptocloccus neoformans growth, differentiation, and virulence [J].
Bahn, YS ;
Cox, GM ;
Perfect, JR ;
Heitman, J .
CURRENT BIOLOGY, 2005, 15 (22) :2013-2020
[4]   Dipeptide boronic acid inhibitors of dipeptidyl peptidase IV: Determinants of potency and in vivo efficacy and safety [J].
Connolly, Beth A. ;
Sanford, David G. ;
Chiluwal, Amrita K. ;
Healey, Sarah E. ;
Peters, Diane E. ;
Dimare, Matthew T. ;
Wu, Wengen ;
Liu, Yuxin ;
Maw, Hlaing ;
Zhou, Yuhong ;
Li, Youhua ;
Jin, Zhiping ;
Sudmeier, James L. ;
Lai, Jack H. ;
Bachovchin, William W. .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (19) :6005-6013
[5]  
Cox JD, 1999, NAT STRUCT BIOL, V6, P1043
[6]   Discovery of a potent, selective, and orally active proteasome inhibitor for the treatment of cancer [J].
Dorsey, Bruce D. ;
Iqbal, Mohamed ;
Chatterjee, Sankar ;
Menta, Ernesto ;
Bernardini, Raffaella ;
Bernareggi, Alberto ;
Cassara, Paolo G. ;
D'Arasmo, Germano ;
Ferretti, Edmondo ;
De Munari, Sergio ;
Oliva, Ambrogio ;
Pezzoni, Gabriella ;
Allievi, Cecilia ;
Strepponi, Ivan ;
Ruggeri, Bruce ;
Ator, Mark A. ;
Williams, Michael ;
MallamoT, John P. .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (04) :1068-1072
[7]   Promoter regulation in Candida albicans and related species [J].
Eckert, Sabine E. ;
Muhlschlegel, Fritz A. .
FEMS YEAST RESEARCH, 2009, 9 (01) :2-15
[8]   New boronic acid fluorescent reporter compounds. 2. A naphthalene-based on-off sensor functional at physiological pH [J].
Gao, XM ;
Zhang, YL ;
Wang, BH .
ORGANIC LETTERS, 2003, 5 (24) :4615-4618
[9]   Targeting virulence: A new paradigm for antifungals [J].
Gauwerky, Katharina ;
Borelli, Claudia ;
Korting, Hans C. .
DRUG DISCOVERY TODAY, 2009, 14 (3-4) :214-222
[10]   Crystal structure of the boronic acid-based proteasome inhibitor bortezomib in complex with the yeast 20S proteasome [J].
Groll, M ;
Berkers, CR ;
Ploegh, HL ;
Ovaa, H .
STRUCTURE, 2006, 14 (03) :451-456